# Top 40 Biotechnology Angel Investors in Canada in June 2026 ## Bootstrapped Debt Financing - Type: Angel - Relevant deals: 3 - Stages: Pre-Seed, Seed - Focus: Software, Information Technology, Apps Bootstrapped Debt Financing ## Tom Williams - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Software, Health Care, Financial Services Tom Williams ## Ray Muzyka - Type: Angel - Location: Edmonton, Alberta, Canada - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Health Care, Software, Information Technology Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001. ## T. Chen Fong - Type: Angel - Location: Calgary, Alberta, Canada - Relevant deals: 2 - Stages: Seed, Angel, Pre-Seed - Focus: Software, Artificial Intelligence, Biotechnology Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy. ## Ajay Agrawal - Type: Angel - Location: Toronto, Ontario, Canada - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series C - Focus: Health Care, Artificial Intelligence, Medical Ajay Agrawal is the Co-Founder of Sanctuary Cognitive Systems Corporation. He previously worked at Queen's School of Business as a Assistant Professor. Ajay Agrawal attended the University of British Columbia. ## Noel Hall - Type: Angel - Relevant deals: 2 - Stages: Seed, Angel - Focus: Biotechnology, Genetics, Life Science Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London. ## Naval Ravikant - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, FinTech, Blockchain Naval Ravikant is an entrepreneur and investor. He is the co-founder and chairman of AngelList. He previously served as the CEO of AngelList. He attended Dartmouth College. ## Balaji Srinivasan - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Blockchain, Cryptocurrency, Software Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC. ## Joe Betts-Lacroix - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 1 - Stages: Seed - Focus: Life Science, Biotechnology, Pharmaceutical Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University. ## Ran Tuttnauer - Type: Angel - Relevant deals: 1 - Stages: Seed, Series A - Focus: Health Care, Big Data, Internet Ran Tuttnauer ## Jacky Chen - Type: Angel - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Software, Health Care, Information Technology Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania. ## Frederic Ors - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Biotechnology Fred has served as our Chief Executive Officer since April 2016. As CEO, he has led the transformation of IMV into a leading clinical-stage immune-oncology company with world-class collaborators and a strong scientific foundation. He has more than 21 years of experience in the biopharmaceutical industry, having served in several managementpositions encompassing business development, intellectual property, strategic planning, pre-marketing, and communication. Before joining IMV, Fred spent 14 years at Medicago serving in many roles of increasing responsibility, most recently as Vice President of Business Development and Strategic Planning. He had been an integral part of Medicago’s success, including securing more than $300M CAN in non-dilutive funding in revenues and future milestones from licensing agreements and government contracts, and the $357M CAN deal acquisition by Mitsubishi Pharma in 2013.Fred is also a Director of CQDM, a biopharmaceutical research consortium and served as second Vice-Chair of the Vaccine Industry Committee of Biotech Canada between 2012 and 2016. Prior to Medicago, Fred was Licensing Manager at the University Paris VII-Denis Diderot, one of the largest sciences and medical university in France. He owns a BSc degree in Biology and a Master’s degree in Biotechnology and Business Management from the University of Angers (France). ## Ethan Oren Perlstein - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Cannabis, Biopharma Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells. ## Jed McCaleb - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Initial Coin Offering - Focus: Internet, Payments, Space Travel Jed McCaleb is based out of San Francisco, California and is the Founder of Vast. Jed previously worked at Ripple as a Co-Founder. ## Lee Lau - Type: Angel - Location: Toronto, Ontario, Canada - Relevant deals: 1 - Stages: Seed, Convertible Note - Focus: Software, Wearables, Internet of Things Lee Lau is a Partner and Co-Founder of Alignvest Management Corporation. Mr. Lau co-founded ATI Technologies in 1985 and built the company into one of the world’s largest supplier of graphic chips and add-in boards to the personal computer industry. In addition to managing the company, Mr. Lau was ATI’s largest shareholder, first employee andresponsible for innovation and development of all products. Mr. Lau helped build ATI into a TSX and NASDAQ listed global market leader, with annual sales in excess of $2.2 billion and over 3,000 employees. ATI was sold in 2006 to Advanced Micro Devices for cash and stock consideration of $5.3 billion. Since then, Mr. Lau has managed his family office investing in a variety of alternative asset products. Prior to founding ATI, Mr. Lau held various design engineering positions with Mitel, Motorola and Plessey.Mr. Lau holds a Masters in Engineering and a BASc from the University of Toronto. ## Lip-Bu Tan - Type: Angel - Location: San Jose, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: Software, Artificial Intelligence, Semiconductor Lip-Bu Tan is based out of Santa Clara, California, and is the Chief Executive Officer of Intel. Lip-Bu previously worked at Cadence Design Systems as a President and Chief Executive Officer. Lip-Bu Tan attended Nanyang Technological University. ## Nilesh Bansal - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: SaaS, Big Data, Hardware Nilesh is co-founder and CTO of Aislelabs and he leads the product development and engineering. Before Aislelabs, Nilesh co-founded Sysomos in 2007. Sysomos went on to become the most advanced social media analytics platform of its kind, serving 70% of the Fortune 50 enterprises, and was later acquired in 2010. Nilesh is also an angel investorand advisor to a number of startups and incubators including Extreme Startups, MaRS Jolt, Bionym, and Granify. Nilesh has significant experience in building robust and scalable software systems, data management platforms and big data analytics solutions. Nilesh's work has appeared in leading research forums worldwide.Nilesh holds a PhD, Computer Science from the University of Toronto, and a B.Tech. Computer Science and Engineering from the Indian Institute of Technology (IIT) Bombay. ## Paul Buchheit - Type: Angel - Location: Mountain View, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Angel - Focus: Software, E-Commerce, Health Care Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University. ## Lance Tracey - Type: Angel - Location: Vancouver, British Columbia, Canada - Relevant deals: 1 - Stages: Seed, Angel, Pre-Seed - Focus: Internet, Software, Communities Lance Tracey - Founding Partner @ Full Stack ## Amarjit Gill - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Convertible Note - Focus: Software, Information Technology, Artificial Intelligence Prior to Maginatics, Amarjit co-founded and helped lead three companies that built lasting technologies. He was co-founder and VP of business development and sales at SiByte (acquired by Broadcom), co-founder and EVP of business development and sales at PA Semi (acquired by Apple), and co-founder and CEO of Agnilux (acquired by Google).Earlierin his career, Amarjit was director of sales for strategic accounts in Digital Equipment Corporation’s semiconductor group. After that business unit was purchased by Intel, he served in a similar capacity for Intel. Amarjit also worked for many years at Texas Instruments in its technical sales organization.Amarjit received a BS degree in Electrical Engineering from San Jose State University. ## Daniel Debow - Type: Angel - Location: Toronto, Ontario, Canada - Relevant deals: 1 - Stages: Seed, Series A, Pre-Seed - Focus: Software, SaaS, FinTech Daniel Debow is the Chair of the Board of Build Canada. He attended the Stanford Law School.Daniel is the Vice President of Product (Demand) at Shopify. He previously worked as an SVP at Salesforce.com, where he drives marketing for Salesforce Work.com, a sales performance management solution that helps Facebook, LinkedIn, Spotify, and otherinnovative companies align, motivate, and drive the performance of their sales teams. Prior to joining Salesforce, Daniel was co-founder and co-CEO of Rypple, a social performance management platform acquired by Salesforce in 2012. Prior to Rypple, Daniel was on the founding team of Workbrain, which provided workforce management solutions to Wal-Mart, Citibank, and other large enterprises. Workbrain grew to $100 million in annual revenues before being acquired by Infor in 2007.A sought after speaker on how social media is changing the workplace, Daniel is a contributor to Fortune.com and the Huffington Post. He’s been widely quoted in Wired, the Financial Times, the Economist and Bloomberg Businessweek. Daniel holds a JD/MBA from the University of Toronto and an LLM in Law, Science and Technology from Stanford University. ## Jon Oringer - Type: Angel - Location: Miami, Florida, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Information Technology, E-Commerce Jon Oringer is the founder and chairman of Shutterstock. ## Rami Essaid - Type: Angel - Location: Damascus, Dimashq, Syria - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: SaaS, Software, News Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering. ## Dan Schultz - Type: Angel - Location: Cleveland, Ohio, United States - Relevant deals: 1 - Stages: Seed - Focus: SaaS, Data Mining, Life Science Dan Schultz ## Collin Terpstra - Type: Angel - Relevant deals: 1 - Stages: Series A - Focus: Medical, Health Care, Biotechnology Collin Terpstra is an allergy specialist. ## Ryan Pawell - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed - Focus: Medical, Biopharma, Biotechnology Ryan Pawell (Founder, Director & Chief Executive Officer) is a Y Combinator alumni, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force,National Institutes of Health, and National Cancer Institute among others. ## Dennis Bennie - Type: Angel - Location: Toronto, Ontario, Canada - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Hardware, Health Care Dennis Bennie is a pioneer, entrepreneur and innovator in the Canadian technology industry. Over the past 20 years, Bennie's entrepreneurial management has powered Mission Electronics, Ingram Canada and Delrina. In 1997, he founded the XDL Venture Capital Fund, focusing on information technology opportunities. The $25 million fund hasyielded exceptional returns to date. One of its most noteworthy investments was a 1997 start-up, Delano Technology Corporation (NASD:DTEC). XDL Intervest, a $150 million fund was started in 1999 and is now fully invested. Bennie currently manages an experienced team investing in private equity opportunities as the XDL Capital Group. From 1988 to 1996, Mr. Bennie was CEO of Delrina Corporation, an independent software developer and publisher, which forged the new software categories of electronic forms and PC fax communications. Under Mr. Bennie's leadership, Delrina pioneered the development of PC fax software called WinFax and became a world leader in the communication software market with annual sales revenue exceeding $130 million. Listed on both the Toronto Stock Exchange and NASDAQ, Delrina cultivated a reputation for leadership, growth and profitability, and completed several public offerings. In November 1995, the company was successfully sold to Symantec Corporation for share consideration valued at $560 million. Mr. Bennie entered the world of technology in 1979, when he co-founded Mission Electronics. He drove the expansion of this leading British audio equipment manufacturer to become a dominant force in the high-end stereo market. In 1982 he sold his interest in Mission Electronics and founded Aviva Software, an independent, mass-market software developer. Under his direction, the company expanded its scope to include software distribution and merged with Ingram Micro Inc. in 1986 to become Canada's largest software distributor. Residing in Toronto, Canada, with his wife Laura and three daughters, Dennis is an avid golfer and runner. A member of the World President's Organization, he also regularly serves on various charitable boards including the Toronto Hospital Board. ## Milad Alucozai - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Pre-Seed - Focus: Biotechnology, Health Care, Medical Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University. ## Haig Farris - Type: Angel - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Biotechnology, Genetics, Life Science Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001. ## Lawrence Bloch - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 1 - Stages: Series B, Debt Financing - Focus: Neuroscience, Therapeutics, Biotechnology Lawrence Bloch, M.D., J.D. is the former President of Infinity. He joined the company as chief financial officer and chief business officer in 2012 and has played a key role in developing and executing the company’s corporate and financial strateBeforeior to joining Infinity in 2012, Dr. Bloch served as chief executive officer of NeurAxon, Inc., acompany focused on developing next-generation pain therapeutics, from 2007 to 2011. Previously, he served as chief business officer and chief financial officer of NitroMed, Inc., raising $150 million in equity and $20 million in venture debt to support the commercial launch of BiDil®. From 1999 to 2004, he served as chief financial officer and vice president of business development of Applied Molecular Evolution, Inc., leading the company’s $101 million initial public offering and $420 million merger with Eli Lilly and Company.Dr. Bloch began his career as an emergency medicine resident physician at Massachusetts General Hospital and Brigham & Women’s Hospital. He holds a J.D. from Harvard Law School, an M.D. from Harvard Medical, School, and an MBA from Harvard Business School. ## Shaz Khan - Type: Angel - Location: Los Angeles, California, United States - Relevant deals: 1 - Stages: Debt Financing - Focus: Hardware, Biometrics, Health Care Shaz Khan is the Chief Strategy Officer/Co-Founder at Vroozi ## Sandra MacPherson - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Genetics, Biotechnology, Medical Device Sandra MacPherson ## bumpkins profile - Type: Angel - Relevant deals: 1 - Stages: Seed, Series A, Pre-Seed - Focus: Health Care, Biotechnology, Robotics blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these. ## Martin LeBlanc - Type: Angel - Location: Montréal, Quebec, Canada - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Biotechnology Martin LeBlanc currently works as the Chief Executive Officer for CellCarta. He previously worked at Caprion Biosciences Inc. as the Co-Founder, President, and CEO. ## Claudette McGowan - Type: Angel - Location: Toronto, Ontario, Canada - Relevant deals: 1 - Stages: Angel, Grant - Focus: Apps, Hospital, Software Claudette is an award-winning Technology Leader with 17+ years of success leading digital transformation, optimizing infrastructure, designing new support approaches to improve service experience. She has led more than 600 IT professionals in the planning, engineering and support of workplace technologies across all BMO branches and office towers.Claudette began her IT career in healthcare at Wellesley Hospital. She later joined the Computing and Telecommunications Division at the Metropolitan Toronto Police Services. Before joining BMO, Claudette spent 4 years at Deloitte where she was a key member of the Technology Management Team.In 2008, Claudette founded Excelovate, a human services company designed to help people and enrich lives through the creation of new products and services. Her work has played a pivotal role in launching the first innovation centre in Aurora, Rap Riderz Innovation Centre.Married and a mother of two, Claudette's commitment to the community is evident in her passion for literacy and everything technological. Claudette has authored five books and in partnership with First Book Canada and other leading corporations, Claudette launched the Black Arts and Innovation Expo (BAIE) as a novel way to celebrate Black History Month. The BAIE promotes diversity and inspires excellence in Science, Technology, Engineering, Arts and Mathematics by showcasing the outstanding achievements of current innovators in the arts, entrepreneurship and technology.Claudette is a recipient of a 2014 Green4Good Visionary award and in 2015 she was hailed as a BBPA Exchange - Woman of Honor and among the Top 100 Black Women to watch in Canada. ## Carol Leaman - Type: Angel - Location: Kitchener, Ontario, Canada - Relevant deals: 1 - Stages: Seed, Angel, Series A - Focus: Health Care, Hospital, Neuroscience Carol Leaman is the CEO of Axonify Inc., a Waterloo-based next generation eLearning company that combines gamification with brain science to revolutionize the way companies think about and deliver training to employees.Axonify makes learning stick with personalized, bite-sized information delivered in a fun, rewarding way that drives real learningtransfer and is saving companies millions. Carol won the Fortune Brainstorm Tech Pitch Competition in July 2012 against 4 other early stage technology companies garnering Axonify worldwide recognition as an emerging leader in the eLearning space.Prior to forming Axonify, Carol was the CEO of PostRank Inc. a social media engagement platform company that she sold to Google in June 2011. Carol is a serial entrepreneur and a Chartered Accountant who has been running and advising early stage technology companies for almost 15 years. ## Wei Guo - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Angel - Focus: Software, Artificial Intelligence, Health Care Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited. ## Greg Wolfond - Type: Angel - Location: New York, New York, United States - Relevant deals: 1 - Stages: Seed, Series A - Focus: Internet, Software, Delivery Greg has a successful track record of bringing innovative solutions to the financial industry. In 1997 Greg co-founded 724 Solutions Inc., a wireless software infrastructure provider. He served as the company’s chief executive officer and led its IPO in 2000.In 1983 he founded Footprint Software Inc., a financial software company, which he sold toIBM in 1995. While at Footprint Software, Greg won the 1994 award for Canada’s Best Managed Private Company. In 1995 he won the award for Canada’s Top 40 Under 40 and in 2000 was named Entrepreneur of the Year.Greg holds a Bachelor of Arts in Computer Science from the University of Western Ontario and a double major, Biochemistry and Life Sciences from the University of Toronto.He sits on the boards of the Ontario Cancer Biomarker Network (OCBN); NoNo Inc., a company specializing in post stroke neuroprotection; and YYZ Pharmatech, which develops tools, targets, and biomarkers for pharmaceutical companies. ## Jeff Mallett - Type: Angel - Location: Vancouver, British Columbia, Canada - Relevant deals: 1 - Stages: Angel, Series A - Focus: E-Commerce, Media and Entertainment, iOS Jeffrey Mallett was most recently the Chairman of SNOCAP, and has a rich history and proven experience in growing technology companies. As president and chief operating officer for Yahoo Inc. from 1995-2002, Mallett helped drive extraordinary growth and success for the company while simultaneously serving as an elected member of the Board ofDirectors. Mallett joined Yahoo in 1995, when the private company consisted of 12 employees and had no revenue. He helped the company go public in 1996, and during his seven year tenure, Mallett helped build Yahoo into one of the most recognizable entertainment and media brands in the world. By 2002, Mallett managed a global workforce of 4,000 employees in 27 countries, with $1 billion in revenue, and had overseen more than 20 acquisitions for the company. Mallett is currently an owner and executive committee member of the San Francisco Giants. Prior to his tenure at Yahoo, Mallett was vice president and general manager of the consumer products division of Novell, Inc. and a member of Novell's global marketing board, where he was involved with the merger of Novell and WordPerfect Corp. in 1994. He was a founding executive team member and vice president of Reference Software, an independent worldwide leader in consumer software language services, and led the company to a successful acquisition by WordPerfect in 1992. He also served as director of the Canadian-based telecommunications company Island Pacific Telephone, where Jeff drove the start-up's growth and development until it was acquired by telecommunications giant Cable and Wireless in 1987. Mallett lives in the San Francisco Bay Area with his wife of 19 years and their two children. ## Robert Simon - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Series A, Seed - Focus: Software, Health Care, SaaS Robert Simon is the Sr. Managing Partner, IT Venture Fund at BDC.